The Validity of Studies that Test the Effectiveness of Psychotherapy

This thesis is a review of the validity of studies on the effectiveness of psychotherapy. Ten randomly selected studies are examined to determine if the validity of the study was affected by threats to statistical conclusion, internal, construct, and external validity. All of the studies examined were published after 1985. The results indicate that validity of the research on the effectiveness of psychotherapy is affected by some threats to validity: History, Testing, and Selection bias, (ie. internal validity). In addition, external validity was affected by the lack of use of appropriate control group, lack of a description of the therapy used and the condition under which it was used, and a lack of a description of placebo group used. The evidence from this thesis suggests a need for improvement in the design of efficacy studies. In addition, the evidence suggests the need for better data reporting so that the research can be replicated

Epeoloides pilosulus (Cresson) Rediscovered in Michigan, with Notes on the Distribution and Status of its Macropis hosts.

Epeoloides pilosulus (Cresson 1878) is one of the rarest bees in North America with only a handful of records since 1960. The last collection in Michigan was made in 1944. Epeoloides pilosulus is a brood parasite of Macropis bees, which until recently had not been collected in Michigan for several decades. Bee surveys in Midland County, Michigan have led to the rediscovery of E. pilosulus in this state – the first record in 74 years. Michigan becomes the fourth state where E. pilosulus has been rediscovered after Connecticut in 2006, New York in 2014 and Maine in 2016, and the sixth region in North America after Nova Scotia in 2002 and Alberta in 2010. State-wide bee surveys have also shown that the principal host, Macropis nuda (Provancher 1882), remains widespread in Michigan, and that Macropis patellata Patton 1880 is newly recorded for the state

Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports

Background: Vaccination remains the cornerstone approach to exiting the current global coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus 2. The novel messenger ribonucleic acid vaccines offer a high level of protection and are widely used throughout the world. With more people receiving the vaccines, better understanding of their relative safety can be reached. In this report, we describe two patients who developed inflammatory myopathy within 48 hours of receiving the Pfizer BNT162b2 vaccine. Case presentation: Patient A, a 55-year-old South East Asian woman, presented with a 6-week history of pruritic facial and torso rash and a 1-week history of worsening proximal myopathy. Her rash first developed 2 days after receiving the first dose of BNT162b2 vaccine. Patient B, a 72-year-old Caucasian woman, presented with a 2-week history of proximal myopathy a day after receiving the second dose of BNT162b2 vaccine. Both patients had elevated creatine kinase on admission. Patient A tested positive for anti-Mi-2a antibody and anti-Ro-52 antibody, while Patient B was positive for anti-fibrillarin antibody. Magnetic resonance imaging subsequently confirmed generalized acute muscle inflammation and subcutaneous inflammation consistent with inflammatory myositis. Both patients did not have a previous history or family history of autoimmune disease. Patients A and B were diagnosed with dermatomyositis and inflammatory myositis, respectively. They were initially treated with pulsed intravenous methylprednisolone followed by oral prednisolone. However, as their conditions were resistant to corticosteroids, both eventually received and responded well to intravenous immunoglobulin therapy. Conclusion: There are previously reported cases of severe acute respiratory syndrome coronavirus 2-induced and other vaccine-related inflammatory myopathies. However, the precise mechanisms are not elucidated. Without more evidence and convincing pathophysiology, it is not possible to conclude that our patients developed inflammatory myopathy because of the vaccine. However, the timing of the disease onset and the lack of previous history raise an important question of this novel messenger ribonucleic acid therapy

The experience of adolescents participating in a randomised clinical trial in the field of mental health: a qualitative study

Background This descriptive study aimed to investigate adolescents’ motivations for participating in a randomised controlled trial (RCT), to explore the understanding that the young people had regarding a number of aspects of the trial design, to examine whether or not they found participation in the trial to be acceptable and what affected this, and to identify whether and how the young people felt that their participation in the RCT impacted on their experience of therapy and on therapeutic change. Methods Seventy-six adolescents who were taking part in a large-scale RCT to evaluate the clinical and cost effectiveness of psychological therapies for depression were interviewed at two time-points after completing therapy. The semi-structured interviews, which included a focus on the young people’s experience of the research study, were analysed using framework analysis. Results The vast majority of adolescents found it acceptable to participate in the clinical trial, and many agreed to participate for reasons of ‘conditional altruism’. However consent was often given without great understanding of the key elements of the trial, including the difference between treatment arms and the randomisation process. Although the adolescents were largely positive about their experiences from taking part, the study raises questions about whether clinical outcomes may be influenced by participation in the research elements of the trial. Conclusions Although adolescents are under-represented in clinical trials, those who do participate are generally positive about the experience; however, careful thought needs to be given to key elements of the trial design and the potential impact of the research participation on clinical outcomes

Ab initio calculations of the hydrogen bond

Recent x-ray Compton scattering experiments in ice have provided useful information about the quantum nature of the interaction between H$_2$O monomers. The hydrogen bond is characterized by a certain amount of charge transfer which could be determined in a Compton experiment. We use ab-initio simulations to investigate the hydrogen bond in H$_2$O structures by calculating the Compton profile and related quantities in three different systems, namely the water dimer, a cluster containing 12 water molecules and the ice crystal. We show how to extract estimates of the charge transfer from the Compton profiles.Comment: 16 pages, 7 figures, to appear in Phys. Rev.